40 min listen
Interview with Dr. Samantha Dale Strasser, CSO and Co-Founder of Transomics Drug Discovery Start-Up "Pepper Bio"
Interview with Dr. Samantha Dale Strasser, CSO and Co-Founder of Transomics Drug Discovery Start-Up "Pepper Bio"
ratings:
Length:
27 minutes
Released:
Jun 1, 2022
Format:
Podcast episode
Description
In this episode, Ayesha and the editorial team spoke with Dr. Samantha Dale Strasser, chief scientific officer and co-founder of biotech start-up Pepper Bio. The company is working to develop therapeutics in the areas of oncology, neurodegenerative disease and inflammatory conditions using a ‘transomics’ drug discovery approach. This involves the integrated analysis of several layers of biological data, including genomic, proteomic, transcriptomic and phosphoproteomic data using novel transomics technologies involving lab methods and AI approaches. Hear more about Pepper Bio as well as Dr. Strasser’s journey from academia to the biotech industry.For more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured
Released:
Jun 1, 2022
Format:
Podcast episode
Titles in the series (100)
Nestlé to Market Oral Microbiome Drug for C. Difficile + WHO Recommends IL-6 Blockers as Life-Saving COVID-19 Treatment by Xtalks Life Science Podcast